Skip to main content
. Author manuscript; available in PMC: 2019 Feb 28.
Published in final edited form as: Vaccine. 2018 Feb 28;36(10):1272–1278. doi: 10.1016/j.vaccine.2018.01.045

Table 3.

Relative odds of influenza among persons who received standard dose inactivated influenza vaccine during the current season by age group, compared with young adults aged 18–49 years.

18–49 years 50–64 years 65–74 years ≥75 years ≥65 years
n (%) n (%) aOR* (95% CI ) n (%) aOR* (95% CI) n (%) aOR* (95% CI) n (%) aOR* (95% CI)
A(H1N1)pdm09 212 (5.5) 195 (7.0) 1.4 (1.1, 1.7) 59 (4.4) 0.8 (0.6, 1.2) 18 (2.2) 0.4 (0.3, 0.7) 77 (3.5) 0.7 (0.5, 0.9)
A(H3N2) 452 (11) 318 (11) 1.1 (0.9, 1.3) 230 (15) 1.7 (1.4, 2.1) 171 (17) 2.1 (1.6, 2.6) 401 (16) 1.9 (1.6, 2.3)
Excluding 2014–15 224 (7.7) 142 (7.1) 1.0 (0.8, 1.3) 96 (10) 1.7 (1.2, 2.3) 75 (12) 2.2 (1.6, 3.2) 171 (11) 1.9 (1.4, 2.4)
Influenza B 144 (3.8) 134 (4.9) 1.4 (1.1, 1.8) 63 (4.6) 1.3 (1.0, 1.9) 18 (2.2) 0.6 (0.4, 1.1) 81 (3.7) 1.1 (0.8, 1.5)
*

aOR = Adjusted relative odds ratio. Adjusted for site, age (spline, month), month of enrollment, sex, race/ethnicity, presence of ≥1 high-risk condition, interval from symptom onset to enrollment, self-reported general health status, and season

CI = 95% confidence interval

Bolded text indicates statistical significance